We are delighted to announce our newest patent and trade marks attorney, Dr Louis Tsai, who registered on 5 August 2016.
Louis joined Phillips Ormonde Fitzpatrick in 2013, having completed his double undergraduate degrees in Science and Engineering at the University of New South Wales, majoring in Medical Immunology, Microbiology and Bioinformatics. Louis then obtained a PhD in medicine in 2012 from Monash University, researching the balance between effective antibody response and autoimmunity.
Since 2008, Louis has been involved in a number of research projects through his employment at the Garvan Institute and Monash University. His scientific work has been published in highly prestigious peer-reviewed journals and recognised by presentations at multiple conferences. During his research, Louis discovered and defined new subsets of CD4 T cells which could be used to identify patients with more severe forms of rheumatoid arthritis and systemic lupus erythematosus.
As a valued member of POF’s Chemistry and Life Sciences team, we congratulate Louis on this significant milestone in his career progression.